Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SAB Biotherapeutics, Inc. | CHIEF OPERATING OFFICER | Employee Stock Option (right to buy) | 140K | Feb 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SABS | SAB Biotherapeutics, Inc. | Feb 21, 2024 | 1 | $0 | 4 | Feb 23, 2024 | CHIEF OPERATING OFFICER |
SABS | SAB Biotherapeutics, Inc. | Mar 14, 2023 | 1 | $0 | 4 | Mar 16, 2023 | Chief Operating Officer |
SABS | SAB Biotherapeutics, Inc. | Sep 13, 2022 | 1 | $0 | 4 | Sep 15, 2022 | CHIEF OPERATING OFFICER |
SABS | SAB Biotherapeutics, Inc. | Mar 16, 2022 | 1 | $0 | 4 | Mar 18, 2022 | Chief Science Officer |
SABS | SAB Biotherapeutics, Inc. | Oct 22, 2021 | 3 | $0 | 4/A | Nov 24, 2021 | Chief Science Officer |
SABS | Big Cypress Acquisition Corp. | Oct 22, 2021 | 0 | $0 | 3 | Oct 22, 2021 | Chief Science Officer |